• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.09% Nasdaq Up 0.45%

    Geron Corporation (GERN)

    -NasdaqGS
    2.68 Up 0.04(1.33%) 11:48AM EDT - Nasdaq Real Time Price
    Prev Close:2.64
    Open:2.66
    Bid:2.68 x 2600
    Ask:2.69 x 13600
    1y Target Est:7.50
    Beta:3.29779
    Earnings Date:Aug 3 - Aug 8 (Est.)
    Day's Range:2.66 - 2.71
    52wk Range:2.30 - 5.30
    Volume:329,808
    Avg Vol (3m):1,696,820
    Market Cap:425.22M
    P/E (ttm):891.67
    EPS (ttm):0.00
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GERNUp 1.33%425.22M
    BMYUp 1.16%126.75B
    GSKUp 1.65%109.04B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):11.47
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.26
    Quarterly EPS Est (Jun-16) :-0.07
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-2.08

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Geron Corporation, a clinical stage biopharmaceutical company, focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback